Theranos Queried on Blood Test Failures by House Democrats
- Lawmakers ask for response by July 14 and a briefing
- Theranos responds that it’s eager to describe improvements
Theranos Inc. Founder Elizabeth Holmes.
Photographer: David Paul Morris/BloombergThis article is for subscribers only.
Democrats in the U.S. House of Representatives sent a letter to troubled blood-testing startup Theranos Inc. asking for more information on the company’s problems and how they’ve affected patients.
The letter from Frank Pallone , Gene Green and Diana DeGette requests information on Theranos’s inaccurate results, potential harm to patients, and how the company is working with regulators to address its deficiencies. Dated June 30, the letter asks for a response by July 14 and a briefing.